MedTrace Logo

Clinical Effects of Limosilactobacillus Reuteri Probiotics as an Adjunct to the Treatment of Periodontitis

NCT05734274 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-11-28

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical efficacy of a probiotic lozenge containing Limosilactobacillus reuteri as an adjunct to the periodontal non-surgical treatment of patients with stage II, grade A, B and C, generalized periodontitis.

Conditions

  • Chronic Periodontitis, Generalized

Interventions

OTHER

Probiotics

Probiotics lozenge containing at least 200 million active Limosilactobacillus reuteri.

OTHER

Negative control

Sugar-free negative control lozenges.

Sponsors & Collaborators

  • Universidade do Porto

    lead OTHER

Principal Investigators

  • André Marques, MDent · Estudante da Especialização de Periodontologia e Implantologia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2024-01-31
Completion
2024-07-31

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05734274 on ClinicalTrials.gov